Bafna Pharmaceuticals Ltd.
| BSE: 532989 |
Sector: Health care |
| NSE: BAFNAPHARM |
ISIN Code: INE878I01014 |
|
BSE LIVE
15:40 | 19 Sep
|
26.85
|
-1.35
(-4.79%)
|
OPEN
27.00
|
HIGH
27.10
|
LOW
26.80
|
|
NSE
15:19 | 19 Sep
|
26.80
|
-0.20
(-0.74%)
|
OPEN
27.00
|
HIGH
28.00
|
LOW
25.70
|
| OPEN |
27.00 |
| PREVIOUS CLOSE |
28.20 |
| VOLUME |
3864 |
| 52-Week high |
35.80 |
| 52-Week low |
20.00 |
| P/E |
|
| Mkt Cap.(Rs cr) |
50 |
| Buy Price |
0.00 |
| Buy Qty |
0.00 |
| Sell Price |
0.00 |
| Sell Qty |
0.00 |
| OPEN |
27.00 |
| PREVIOUS CLOSE |
27.00 |
| VOLUME |
5273 |
| 52-Week high |
35.95 |
| 52-Week low |
22.00 |
| P/E |
|
| Mkt Cap.(Rs cr) |
50 |
| Buy Price |
26.80 |
| Buy Qty |
795.00 |
| Sell Price |
27.75 |
| Sell Qty |
115.00 |
| OPEN |
27.00 |
| CLOSE |
28.20 |
| VOLUME |
3864 |
| 52-Week high |
35.80 |
| 52-Week low |
20.00 |
| P/E |
|
| Mkt Cap.(Rs cr) |
50 |
| Buy Price |
0.00 |
| Buy Qty |
0.00 |
| Sell Price |
0.00 |
| Sell Qty |
0.00 |
| OPEN |
27.00 |
| PREVIOUS CLOSE |
27.00 |
| VOLUME |
5273 |
| 52-Week high |
35.95 |
| 52-Week low |
22.00 |
| P/E |
|
| Mkt Cap.(Rs cr) |
50.10 |
| Buy Price |
26.80 |
| Buy Qty |
795.00 |
| Sell Price |
27.75 |
| Sell Qty |
115.00 |
Filter:
Bafna Pharmaceuticals Ltd. (BAFNAPHARM) - Nine Monthly Result
Particulars ( cr) |
Dec '16 |
Dec '15 |
Dec '14 |
Dec '13 |
Dec '12 |
| Net Sales/Income From Operations |
53.52 |
59.04 |
123.80 |
138.25 |
120.33 |
| Other Income |
1.15 |
1.22 |
0.73 |
1.03 |
1.43 |
| Total Income |
54.67 |
60.26 |
124.53 |
139.28 |
121.76 |
| Total Expenditure |
52.69 |
53.73 |
77.68 |
121.07 |
101.99 |
| Operating Profit |
1.98 |
6.52 |
46.85 |
18.21 |
19.77 |
| Interest |
9.19 |
9.04 |
9.79 |
8.66 |
7.96 |
| Gross Profit |
-7.21 |
-2.52 |
37.06 |
9.55 |
11.81 |
| Depreciation |
3.05 |
2.35 |
4.88 |
4.50 |
5.39 |
| PBT |
-10.26 |
-4.87 |
32.18 |
5.05 |
6.42 |
| Tax |
-0.16 |
0.47 |
3.30 |
1.71 |
1.88 |
| Net Profit/(Loss) |
-10.10 |
-5.34 |
28.88 |
3.34 |
4.54 |
| Minority Interest After NP |
- |
- |
- |
- |
- |
| Net Profit after Minority Interest |
- |
- |
- |
- |
- |
| Exceptional Items |
0.00 |
0.00 |
-2.41 |
0.00 |
0.00 |
| Profit After Exceptional Items |
-10.10 |
-5.34 |
31.29 |
3.34 |
4.54 |
| Equity Share Capital |
18.66 |
18.66 |
18.66 |
18.66 |
18.66 |
| Reserves Excluding Revaluation Reserves |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| EPS |
| Basic EPS |
-5.41 |
-2.86 |
15.48 |
1.79 |
2.43 |
| Public Share Holding |
| No Of Shares (Crores) |
0 |
0 |
0.12 |
1.18 |
1.16 |
| Share Holding (%) |
0.00 |
0.00 |
63.05 |
63.50 |
61.96 |
| Promoters and Promoter Group Shareholding |
| a) Pledged/Encumbered |
| - Number of Shares (Crores) |
0 |
0 |
0.15 |
0.15 |
0.13 |
| - Per. of Shares (as a % of the total sh. of prom. and promoter group) |
0.00 |
0.00 |
22.19 |
22.47 |
18.08 |
| - Per. of Shares (as a % of the total Share Cap. of the company) |
0.00 |
0.00 |
8.20 |
8.20 |
6.88 |
| b) Non-encumbered |
| - Number of Shares (Crores) |
0 |
0 |
0.54 |
0.53 |
0.58 |
| - Per. of shares (as a % of the total sh. of prom. and promoter group) |
0.00 |
0.00 |
77.81 |
77.53 |
81.92 |
| - Per. of shares (as a % of the total Share Cap. of the company) |
0.00 |
0.00 |
28.75 |
28.30 |
31.16 |
|
Note :
|
PBT include deferred tax and fringe benefit tax Net profit figures include extra-ordinary items income/expenditure. |
Quick Links for Bafna Pharmaceuticals:
